These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28702674)

  • 1. Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases.
    Csaky K; Ferris F; Chew EY; Nair P; Cheetham JK; Duncan JL
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3456-3463. PubMed ID: 28702674
    [No Abstract]   [Full Text] [Related]  

  • 2. Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium.
    Csaky KG; Richman EA; Ferris FL
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):479-89. PubMed ID: 18234989
    [No Abstract]   [Full Text] [Related]  

  • 3. Core outcomes for geographic atrophy trials.
    Krezel AK; Hogg R; Lohfeld L; Chakravarthy U; Azuara-Blanco A
    Br J Ophthalmol; 2020 Sep; 104(9):1196-1202. PubMed ID: 31848211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomic Clinical Trial Endpoints for Nonexudative Age-Related Macular Degeneration.
    Schaal KB; Rosenfeld PJ; Gregori G; Yehoshua Z; Feuer WJ
    Ophthalmology; 2016 May; 123(5):1060-79. PubMed ID: 26952592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures.
    Yehoshua Z; Rosenfeld PJ; Albini TA
    Semin Ophthalmol; 2011 May; 26(3):167-80. PubMed ID: 21609230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scanning laser ophthalmoscope imaging stabilized microperimetry in dry age-related macular degeneration.
    Hartmann KI; Bartsch DU; Cheng L; Kim JS; Gomez ML; Klein H; Freeman WR
    Retina; 2011; 31(7):1323-31. PubMed ID: 21540764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CLINICAL ENDPOINTS FOR THE STUDY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Sadda SR; Chakravarthy U; Birch DG; Staurenghi G; Henry EC; Brittain C
    Retina; 2016 Oct; 36(10):1806-22. PubMed ID: 27652913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience With a Subretinal Cell-based Therapy in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration.
    Ho AC; Chang TS; Samuel M; Williamson P; Willenbucher RF; Malone T
    Am J Ophthalmol; 2017 Jul; 179():67-80. PubMed ID: 28435054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal Sensitivity at the Junctional Zone of Eyes With Geographic Atrophy Due to Age-Related Macular Degeneration.
    Hariri AH; Tepelus TC; Akil H; Nittala MG; Sadda SR
    Am J Ophthalmol; 2016 Aug; 168():122-128. PubMed ID: 27189929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-luminance visual acuity and microperimetry in age-related macular degeneration.
    Wu Z; Ayton LN; Guymer RH; Luu CD
    Ophthalmology; 2014 Aug; 121(8):1612-9. PubMed ID: 24661863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral geographic atrophy: spontaneous visual improvement after loss of vision in the fellow eye.
    Bissell AJ; Yalcinbayir O; Akduman L
    Acta Ophthalmol Scand; 2005 Aug; 83(4):514-5. PubMed ID: 16029285
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia.
    Charbel Issa P; Helb HM; Holz FG; Scholl HP;
    Am J Ophthalmol; 2008 Jan; 145(1):169-175. PubMed ID: 17981256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on ocular gene therapy and advances in treatment of inherited retinal diseases and exudative macular degeneration.
    Garoon RB; Stout JT
    Curr Opin Ophthalmol; 2016 May; 27(3):268-73. PubMed ID: 26918787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab.
    Parravano M; Oddone F; Tedeschi M; Schiano Lomoriello D; Chiaravalloti A; Ripandelli G; Varano M
    Retina; 2009 Mar; 29(3):329-34. PubMed ID: 19092732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can the Onset of Atrophic Age-Related Macular Degeneration Be an Acceptable Endpoint for Preventative Trials?
    Wu Z; Guymer RH
    Ophthalmologica; 2020; 243(6):399-403. PubMed ID: 32805732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration.
    Wu Z; Ayton LN; Luu CD; Guymer RH
    JAMA Ophthalmol; 2015 Apr; 133(4):442-8. PubMed ID: 25632841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel C8orf37 Mutations in Patients with Early-onset Retinal Dystrophy, Macular Atrophy, Cataracts, and High Myopia.
    Katagiri S; Hayashi T; Yoshitake K; Akahori M; Ikeo K; Gekka T; Tsuneoka H; Iwata T
    Ophthalmic Genet; 2016; 37(1):68-75. PubMed ID: 25113443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive Cone Dysfunction and Geographic Atrophy of the Macula in Late Stage Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC).
    Chen CJ; Goldberg MF
    Ophthalmic Genet; 2016; 37(1):81-5. PubMed ID: 24564716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing clinical trials for age-related geographic atrophy of the macula: enrollment data from the geographic atrophy natural history study.
    Sunness JS; Applegate CA; Bressler NM; Hawkins BS
    Retina; 2007 Feb; 27(2):204-10. PubMed ID: 17290203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of macular function changes in early (AREDS 2) and intermediate (AREDS 3) age-related macular degeneration.
    Vujosevic S; Smolek MK; Lebow KA; Notaroberto N; Pallikaris A; Casciano M
    Ophthalmologica; 2011; 225(3):155-60. PubMed ID: 21150232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.